This compound is a pyridazinecarboxylic acid derivative that serves as a pharmaceutical intermediate used in the manufacture of deucravacitinib.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 2245111-18-4
Deucravacitinib
active pharmaceutical ingredient
3-Pyridazinecarboxylic acid, 6-chloro-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-
Pharmaceutical intermediate for deucravacitinib synthesis
Lithium 4,6-Dichloropyridazine-3-carboxylate
Pharmaceutical intermediate for deucravacitinib
Methyl 4,6-dichloropyridazine-3-carboxylate
Pharmaceutical intermediate for deucravacitinib
(2-Amino-5-nitrophenyl)(2-chlorophenyl)methanone Phthalimido
Pharmaceutical impurity reference standard
(2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methanol hydrochloride
pharmaceutical intermediate
4-Amino-3-fluoropyridine
Pharmaceutical intermediate for BACE1 inhibitors
Py-MAA-Val-Cit-PAB-MMAE
antibody-drug conjugate linker payload
6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]pyridazine-3-carboxylic acid
KVBLKXICHZUDRD-UHFFFAOYSA-N
CN1C=NC(=N1)C2=C(C(=CC=C2)NC3=CC(=NN=C3C(=O)O)NC(=O)C4CC4)OC